Of the identified 95 individuals with confirmed ABCC6 variant(s) and clinical manifestations reported between infancy and adolescence, 53 (55.8%) had a reported diagnosis or phenotype consistent with GACI2, and 42 (44.2%) had PXE. This evidence concerns the gene ABCC6 and pseudoxanthoma elasticum (inherited or acquired).